EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Impact of bronchial thermoplasty on exacerbation rates, quality of life, and healthcare utilization in severe asthma: a systematic review and meta-analysis of long-term outcomes.

Abdulelah Alotaibi, Linah Alhassan, Amwaj Alshemmri, Abdullah Mastour Alotaibi, Yosof Essam Rihan, Abdulaziz Alassaf, Mohammad Saleh Dairi

Multidisciplinary Respiratory Medicine · 2026-11-12 · 21 (Vol. 21 (2026)) · 1106

DOI: 10.5826/mrm.2026.1106 ↗
AbstractBibliografische Angaben

Abstract

Background: Bronchial thermoplasty (BT) utilizes regulated radiofrequency radiation to diminish airway smooth muscle and enhance asthma management. This study aimed to assess the long-term effects of BT on asthma exacerbation rates, quality of life, healthcare utilization, lung function, and safety in adults with severe asthma. Methods: We searched PubMed, Web of Science, and Scopus through August 2024. Seventeen studies (randomized controlled trials and observational cohorts) with ≥12-month follow-up were included. Outcomes assessed were exacerbations, quality of life, healthcare utilization, lung function, and adverse events. Data were synthesized using random-effects models. Results: BT was consistently associated with reductions in severe exacerbations and emergency visits. Improvements in asthma-related quality of life were observed and remained evident during long-term follow-up. In contrast, changes in lung function were modest and often not significant. Reported adverse events were generally mild, occurred mainly in the early weeks after the procedure, and no additional long-term safety concerns were identified. Conclusions: BT provides sustained clinical benefits in carefully selected severe asthma patients, improving quality of life and reducing exacerbations without long-term safety concerns.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →